RxDoctor Payments Data

Erica Blackburn, APRN

Family · Pikeville, KYNPI 1730518424

Payments from drug & device makers

$1,093in general payments, 2019–2025

Across 68 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$592
  • GSK$137
  • Grifols USA, LLC$114
  • Lilly USA, LLC$84
  • AstraZeneca$35
  • Xeris Pharmaceuticals, Inc.$23
  • plus $109 from 7 others

What the payments were for

  • Food & beverage$1,093100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,093 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,728
Medicare patients
28
Services billed
80

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide98$113,895
Trelegy ElliptaFluticasone/Umeclidin/Vilanter72$74,265
OzempicSemaglutide55$52,021
FarxigaDapagliflozin Propanediol48$50,018
EliquisApixaban23$24,685
JardianceEmpagliflozin34$23,272
LinzessLinaclotide35$21,275
TrulicityDulaglutide13$19,092
Repatha SureclickEvolocumab24$13,774
EntrestoSacubitril/Valsartan11$10,725
Breo ElliptaFluticasone/Vilanterol18$7,138
SymbicortBudesonide/Formoterol Fumarate23$6,918
Combivent RespimatIpratropium/Albuterol Sulfate13$6,358
BreynaBudesonide/Formoterol Fumarate21$5,589
Albuterol Sulfate HfaAlbuterol Sulfate126$5,355

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$84$132,986111 claims
GSKTrelegy Ellipta, Breo Ellipta$137$81,40490 claims
AstraZenecaFarxiga, Symbicort$35$56,93671 claims
PfizerEliquis$13$24,68523 claims
AbbVieLinzess$592$21,27535 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.

Other family in Pikeville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →